Shennon Biotechnologies
Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.
$12MFunding
ParticipantAV
Atypical Ventures
Activity from announced rounds
Activity in this selectionsamuel-udotong-e24ebb7f
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $122M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionPhoenixAI
AI-native analytical database enabling AI agents to query live and historical enterprise data at sub-second latency
$80MSeries B
Role not disclosedVentaris Surgical
Develops a ureteroscopic system for complete kidney stone clearance
$30MSeries A
Role not disclosed